Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Bionik Laboratories Corp. from Q3 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Bionik Laboratories Corp. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q3 2022 to Q1 2023.
  • Bionik Laboratories Corp. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Mar 2023 was $38.2K.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Bionik Laboratories Corp. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $38.2K 31 Mar 2023 10-K 21 Jun 2023
Q4 2022 $38.2K 31 Dec 2022 10-Q 08 Feb 2023
Q3 2022 $38.2K 30 Sep 2022 10-Q 09 Nov 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.